2024 Research Report | Contraceptive Drugs Market Poised for Expansion, Predicted to Reach USD 12.47 Billion by 2030
30. Oktober 2024 11:28 ET
|
Research and Markets
Dublin, Oct. 30, 2024 (GLOBE NEWSWIRE) -- The "Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's...
Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access
16. Oktober 2024 09:00 ET
|
Myriad Genetics, Inc.
Myriad Genetics announced a strategic partnership with jscreen to advance health equity and genetic testing access.
Women’s Health Therapeutics Market Size to Reach USD 61.6 Billion by 2032, Driven by Rising Awareness & Technological Advancements - SNS Insider
15. Oktober 2024 09:10 ET
|
SNS Insider pvt ltd
Pune, Oct. 15, 2024 (GLOBE NEWSWIRE) -- According to SNS Insider, The Women’s Health Therapeutics Market was estimated to be USD 43.21 billion in 2023 and is projected to be valued at USD 61.6...
£302+ Million UK Pregnancy Testing Kits Market Forecast, 2029: Heightened Awareness, Convenience, and Technological Innovations Driving Industry Growth, Dominated by the South-East
10. Oktober 2024 04:17 ET
|
Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "United Kingdom Pregnancy Testing Kits Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...
Pregnancy Detection Kits Industry Report 2024, Featuring Key Players Alere, Church & Dwight, Confirm BioSciences, CVS Health, Mankind Pharma, Philippine Blue Cross Biotech, Prestige Brands and Quidel
08. Oktober 2024 04:03 ET
|
Research and Markets
Dublin, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The "Pregnancy Detection Kits - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Pregnancy...
Mifepristone and Misoprostol are Not “Controlled Dangerous Substances”: The American College of Medical Toxicology Issues Position Statement
30. September 2024 11:29 ET
|
American College of Medical Toxicology
Phoenix, AZ, Sept. 30, 2024 (GLOBE NEWSWIRE) -- In May of 2024, Louisiana enacted a law classifying mifepristone and misoprostol as Schedule IV controlled dangerous substances, akin to medications...
U.S. Women's Health Market Size, Share & Trends Analysis Report 2024-2030: Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, PCOS
20. September 2024 04:04 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "U.S. Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Endometriosis & Uterine Fibroids), By Age (50...
U.S. Contraceptive Market Report 2024-2030: Pills, Intrauterine Devices (IUD), Condoms, Vaginal Ring, Subdermal Implants, Injectables Size, Share & Trends Analysis
19. September 2024 10:43 ET
|
Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "U.S. Contraceptive Market Size, Share & Trends Analysis Report By Product (Pills, Intrauterine Devices (IUD), Condoms, Vaginal Ring, Subdermal...
Women's Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030) Featuring Profiles of Amgen, Teva Pharma, Merck & Co, Bayer, AbbVie
18. September 2024 04:14 ET
|
Research and Markets
Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Women Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's...
OC/LEP (Oral Contraception, Low Dose Estrogen Progestin) Market Research 2024 Featuring Johnson & Johnson, Sanofi, Novartis, Pfizer, Bayer, Merck, Teva, Abbvie, Viatris, and Cipla
12. September 2024 09:55 ET
|
Research and Markets
Dublin, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The "Global OC/LEP Market (2024 Edition): Analysis by Type (Combination Contraceptives Pills, Progestin-only Pills), By Distribution Channel, By Region, By...